Delivery Order SPE2DB20D2014-SPE2DB25FC81A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,148.66 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. WIXELA is a combination inhaled medication used in respiratory disease treatment, representing a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,450.80 firm fixed-price contract is for the WIXELA 250-50 INHUB 60S medication. It is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of WIXELA 500-50 INHUB 60S pharmaceutical products, valued at $1,362.00 with a completion date of September 12, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract has a firm fixed price of $2,013.63 and an ultimate completion date of September 25, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,960.76 firm fixed-price contract is for the supply of WIXELA 250-50 INHUB 60S, a respiratory medication. The award has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC81ADelivery Order
The Defense Logistics Agency awarded a $2,141.04 delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, which is a child order under a larger contract vehicle, involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. WIXELA is a combination inhalation medication used in respiratory therapy, reflecting AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad range of medications and medical supplies to support military healthcare programs and other federal health systems. The company's substantial IDC with the DLA enables it to fulfill diverse medical supply requirements through competitive delivery orders on a firm fixed-price basis, making it a versatile vendor for the agency's pharmaceutical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/21/25 |